In 2012 Chang et al. demonstrated that the in vivo treatment with curcumin in combination with T cell transfer increases tumor infiltration and restores the antitumor activity of transferred CD8 T cells by inhibiting IDO and TGFβ production by tumor cells [49]. The gene discussed is TGFB1; the disease is neoplasm.